X
With a large supply base in high-tariff countries and no clarity on how suppliers would pass on costs, a U.S. pharmaceutical company knew it had to take urgent, pre-emptive action.
It brought in GEP to take a hard look at its $12 billion in spend, uncover vulnerabilities and manage tariff risk.
See how GEP identified over $3 billion exposed to tariff impact, conducted risk profiling, and is developing strategies and execution roadmaps to reduce the Fortune 500 pharma’s tariff liability.
Key Highlights:
- Full diagnostic of tariff exposure across direct and indirect spend
- Real-time tariff tracking and visibility via dynamic dashboard
- Risk frameworks and heat maps to prioritize mitigation actions
This case study is essential reading for procurement and supply chain leaders who want to implement effective risk and cost management strategies.